68Ga-satoreotide trizoxetan is a new type of imaging agent used in a special scan called a PET/CT scan. This medication helps doctors see certain types of cancer cells in the body more clearly. In this study, it is used to help find and understand high-grade neuroendocrine lung cancer. The medication is injected into the body, and then it travels to the cancer cells, making them light up on the scan. This helps doctors see where the cancer is located and how much of it is present, which can be very helpful in planning treatment.

Large Cell Neuroendocrine Lung Cancer – Large cell neuroendocrine lung cancer is a type of lung cancer characterized by large, abnormal cells that originate from neuroendocrine cells in the lungs. It is considered a high-grade tumor, meaning it tends to grow and spread more quickly than low-grade tumors. The disease often begins in the central part of the lungs and can invade nearby tissues or spread to other parts of the body. As it progresses, patients may experience symptoms such as cough, chest pain, and difficulty breathing. The aggressive nature of this cancer often leads to rapid changes in health status.

Small Cell Lung Cancer – Small cell lung cancer is a fast-growing type of lung cancer that primarily arises in the bronchi, the main airways of the lungs. It is characterized by small, round cancer cells that multiply quickly and form large tumors. This type of cancer often spreads early to other parts of the body, including the lymph nodes, liver, bones, and brain. Symptoms may include persistent cough, chest pain, shortness of breath, and weight loss. Due to its rapid progression, small cell lung cancer can lead to significant health changes in a short period.